home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

DNA Vaccine Could Slow Leukemia Progression

  October, 21 2003 8:54
your information resource in human molecular genetics
A DNA vaccine can slow disease progression and prolong survival in a mouse model of leukemia, according to a report in the November issue of Nature Medicine.

Rose Ann Padua and coworkers developed a vaccine with pieces of DNA encoding PML-RAR-alpha, a tumor-associated protein, and fragment C of tetanus toxin, a potent immune system stimulant. When injected into a mouse model of acute promyelocytic leukemia (APL), a rare cancer of the white blood cells, the vaccine induced the immune system to make antibodies against the PML-RAR-alpha protein, which is commonly found in APL cancer cells.

The vaccine was even more effective at increasing survival when used in combination with all-trans retinoic acid (ATRA), a drug currently used to treat APL. The vaccine-ATRA duo was even more effective than ATRA alone. The researchers suggest the vaccine could eventually be used with ATRA to prolong clinical remission in human patients.

Author contact:

Rose Ann Padua
King's College Hospital
London, UK
Tel: +44 20 7848 5825
E-mail: RoseAnn.Padua@kingsch.nhs.uk

Also available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.